vs
牛津地产（IIPR）与IRONWOOD PHARMACEUTICALS INC（IRWD）财务数据对比。点击上方公司名可切换其他公司
牛津地产的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.4倍（$66.7M vs $47.7M），牛津地产净利率更高（47.8% vs -4.8%，领先52.5%），牛津地产同比增速更快（-13.1% vs -47.3%），过去两年牛津地产的营收复合增速更高（-6.0% vs -20.2%）
牛津地产是一家加拿大跨国企业，业务涵盖房地产投资、开发与物业管理。其投资组合包含写字楼、零售、工业、多户住宅、生命科学及酒店类资产。该公司1960年以私营企业形式创立，自2003年起成为安大略省市政雇员退休系统（OMERS）的全资子公司，总部设于多伦多，在纽约、伦敦、澳大利亚、新加坡及卢森堡均设有区域总部。
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
IIPR vs IRWD — 直观对比
营收规模更大
IIPR
是对方的1.4倍
$47.7M
营收增速更快
IIPR
高出34.2%
-47.3%
净利率更高
IIPR
高出52.5%
-4.8%
两年增速更快
IIPR
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.7M | $47.7M |
| 净利润 | $31.8M | $-2.3M |
| 毛利率 | — | — |
| 营业利润率 | 47.8% | 14.3% |
| 净利率 | 47.8% | -4.8% |
| 营收同比 | -13.1% | -47.3% |
| 净利润同比 | -20.4% | -200.9% |
| 每股收益（稀释后） | $1.07 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IIPRIRWD
| Q4 25 | $66.7M | $47.7M | ||
| Q3 25 | $64.7M | $122.1M | ||
| Q2 25 | $62.9M | $85.2M | ||
| Q1 25 | $71.7M | $41.1M | ||
| Q4 24 | $76.7M | $90.5M | ||
| Q3 24 | $76.5M | $91.6M | ||
| Q2 24 | $79.8M | $94.4M | ||
| Q1 24 | $75.5M | $74.9M |
净利润IIPRIRWD
| Q4 25 | $31.8M | $-2.3M | ||
| Q3 25 | $29.3M | $40.1M | ||
| Q2 25 | $26.0M | $23.6M | ||
| Q1 25 | $31.1M | $-37.4M | ||
| Q4 24 | $40.0M | $2.3M | ||
| Q3 24 | $40.2M | $3.6M | ||
| Q2 24 | $42.0M | $-860.0K | ||
| Q1 24 | $39.4M | $-4.2M |
营业利润率IIPRIRWD
| Q4 25 | 47.8% | 14.3% | ||
| Q3 25 | 45.5% | 61.8% | ||
| Q2 25 | 45.9% | 53.2% | ||
| Q1 25 | 47.4% | -70.7% | ||
| Q4 24 | 54.7% | 34.8% | ||
| Q3 24 | 54.8% | 28.0% | ||
| Q2 24 | 53.1% | 26.5% | ||
| Q1 24 | 55.7% | 14.7% |
净利率IIPRIRWD
| Q4 25 | 47.8% | -4.8% | ||
| Q3 25 | 45.3% | 32.8% | ||
| Q2 25 | 41.4% | 27.7% | ||
| Q1 25 | 43.3% | -90.9% | ||
| Q4 24 | 52.2% | 2.5% | ||
| Q3 24 | 52.6% | 4.0% | ||
| Q2 24 | 52.6% | -0.9% | ||
| Q1 24 | 52.3% | -5.6% |
每股收益（稀释后）IIPRIRWD
| Q4 25 | $1.07 | $0.01 | ||
| Q3 25 | $0.97 | $0.23 | ||
| Q2 25 | $0.86 | $0.14 | ||
| Q1 25 | $1.03 | $-0.23 | ||
| Q4 24 | $1.35 | $0.03 | ||
| Q3 24 | $1.37 | $0.02 | ||
| Q2 24 | $1.44 | $-0.01 | ||
| Q1 24 | $1.36 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.6M | $215.5M |
| 总债务越低越好 | $393.7M | — |
| 股东权益账面价值 | $1.8B | $-261.8M |
| 总资产 | $2.4B | $396.9M |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资IIPRIRWD
| Q4 25 | $47.6M | $215.5M | ||
| Q3 25 | $41.9M | $140.4M | ||
| Q2 25 | $104.9M | $92.9M | ||
| Q1 25 | $133.3M | $108.5M | ||
| Q4 24 | $151.2M | $88.6M | ||
| Q3 24 | $172.4M | $88.2M | ||
| Q2 24 | $160.9M | $105.5M | ||
| Q1 24 | $173.5M | $121.5M |
总债务IIPRIRWD
| Q4 25 | $393.7M | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
股东权益IIPRIRWD
| Q4 25 | $1.8B | $-261.8M | ||
| Q3 25 | $1.9B | $-264.2M | ||
| Q2 25 | $1.9B | $-308.2M | ||
| Q1 25 | $1.9B | $-334.1M | ||
| Q4 24 | $1.9B | $-301.3M | ||
| Q3 24 | $1.9B | $-311.3M | ||
| Q2 24 | $1.9B | $-321.7M | ||
| Q1 24 | $2.0B | $-330.5M |
总资产IIPRIRWD
| Q4 25 | $2.4B | $396.9M | ||
| Q3 25 | $2.3B | $396.1M | ||
| Q2 25 | $2.3B | $342.9M | ||
| Q1 25 | $2.4B | $327.2M | ||
| Q4 24 | $2.4B | $350.9M | ||
| Q3 24 | $2.4B | $389.5M | ||
| Q2 24 | $2.4B | $395.6M | ||
| Q1 24 | $2.4B | $438.8M |
负债/权益比IIPRIRWD
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.2M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | — | $74.6M |
| 自由现金流率自由现金流/营收 | — | 156.3% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 6.22× | — |
| 过去12个月自由现金流最近4个季度 | — | $127.0M |
8季度趋势，按日历期对齐
经营现金流IIPRIRWD
| Q4 25 | $198.2M | $74.6M | ||
| Q3 25 | $45.6M | $47.6M | ||
| Q2 25 | $48.4M | $-15.1M | ||
| Q1 25 | $54.2M | $20.0M | ||
| Q4 24 | $258.4M | $15.2M | ||
| Q3 24 | $64.9M | $9.9M | ||
| Q2 24 | $64.2M | $33.5M | ||
| Q1 24 | $71.6M | $45.0M |
自由现金流IIPRIRWD
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
自由现金流率IIPRIRWD
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
资本支出强度IIPRIRWD
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
现金转化率IIPRIRWD
| Q4 25 | 6.22× | — | ||
| Q3 25 | 1.56× | 1.19× | ||
| Q2 25 | 1.86× | -0.64× | ||
| Q1 25 | 1.75× | — | ||
| Q4 24 | 6.46× | 6.74× | ||
| Q3 24 | 1.61× | 2.71× | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
